SLS
SELLAS Life Sciences Group, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.49
+5.11%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-23.6%
Return on equity
-22.3%
Return on assets
-25.4%
Return on invested capital
0.00x
Asset turnover
-$28.4M
Cash from operations
$0.69
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026